Cargando…
Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival
OBJECTIVES: The advent of the tyrosine kinase inhibitors has markedly changed the prognostic outlook for patients with Ph(+) and/or BCR-ABL1(+) chronic myeloid leukemia (CML). This study was designed to assess the overall survival (OS) of Nigerian patients with CML receiving imatinib therapy and to...
Autores principales: | Oyekunle, Anthony A., Durosinmi, Muheez A., Bolarinwa, Ramoni A., Owojuyigbe, Temilola, Salawu, Lateef, Akinola, Norah O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915783/ https://www.ncbi.nlm.nih.gov/pubmed/27375361 http://dx.doi.org/10.4137/CMBD.S31562 |
Ejemplares similares
-
Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia
por: Oyekunle, Anthony A., et al.
Publicado: (2015) -
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report
por: Ahmed, Ibrahim O., et al.
Publicado: (2021) -
Degrees of Kidney Disease in Nigerian Adults with Sickle-Cell Disease
por: Aneke, John C., et al.
Publicado: (2014) -
Challenges to Care and Medication Adherence of Patients With Chronic Myeloid Leukemia in a Resource Limited Setting: A Qualitative Study
por: Bolarinwa, R A, et al.
Publicado: (2017) -
The Inflammatory Response to Surgery in Sickle Cell Disease Patients Undergoing Cholecystectomy
por: Adisa, Adewale O., et al.
Publicado: (2019)